Anxo Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 421.664 million compared to TWD 432.302 million a year ago. Operating income was TWD 23.422 million compared to TWD 26.659 million a year ago. Net income was TWD 13.014 million compared to TWD 18.132 million a year ago. Basic earnings per share was TWD 0.29 compared to TWD 0.42 a year ago.